FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

17037711000001106: Olanzapine 210mg powder and solvent for suspension for injection vials 1 vial (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 05-May 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
59465301000001119 Olanzapine 210mg powder and solvent for suspension for injection vials 1 vial (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
60833701000001117 Olanzapine embonate 210mg powder and solvent for suspension for injection vials 1 vial en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Olanzapine 210mg powder and solvent for suspension for injection vials 1 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Olanzapine 210mg powder and solvent for suspension for injection vials 1 vial Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Olanzapine 210mg powder and solvent for suspension for injection vials 1 vial Has VMP Olanzapine 210mg powder and solvent for suspension for injection vials true Inferred relationship Existential restriction modifier
Olanzapine 210mg powder and solvent for suspension for injection vials 1 vial VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Olanzapine 210mg powder and solvent for suspension for injection vials 1 vial VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Olanzapine 210mg powder and solvent for suspension for injection vials 1 vial Has specific active ingredient Olanzapine pamoate monohydrate false Inferred relationship Existential restriction modifier
Olanzapine 210mg powder and solvent for suspension for injection vials 1 vial Has dispensed dose form Powder and solvent for suspension for injection true Inferred relationship Existential restriction modifier
Olanzapine 210mg powder and solvent for suspension for injection vials 1 vial Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Olanzapine true Inferred relationship Existential restriction modifier
Olanzapine 210mg powder and solvent for suspension for injection vials 1 vial Has specific active ingredient Olanzapine embonate monohydrate true Inferred relationship Existential restriction modifier
Olanzapine 210mg powder and solvent for suspension for injection vials 1 vial Has basis of strength substance Olanzapine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Zypadhera 210mg powder and solvent for suspension for injection vials (Eli Lilly and Company Ltd) 1 vial Is a True Olanzapine 210mg powder and solvent for suspension for injection vials 1 vial Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start